Company Search:
Advanced Search
Sponsored Links
MediRox AB Company Snapshot
MediRox AB operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares MediRox AB with three other pharmaceutical manufacturers in Europe: IDL Biotech AB (2015 sales of 28.52 million Swedish Kronor [US$3.19 million] ), Epigenomics AG of Germany (2.08 million Euro [US$2.21 million] of which 75% was Product sales (own and third party)), and Biohit Oyj which is based in Finland (6.05 million Euro [US$6.43 million] ).

Sales Analysis. MediRox AB reported sales of SEK 33.86 million (US$3.78 million) for the year ending December of 2015. This represents an increase of 9.6% versus 2014, when the company's sales were SEK 30.90 million. This was the third consecutive year of growth at MediRox AB.
  Stock Performance Chart for MediRox AB
  Stock Data: Recent Stock Performance:
  Current Price (12/16/2016): 13.55
(Figures in Swedish Kronor)
1 Week -2.2%   13 Weeks -12.6%  
4 Weeks 18.3%   52 Weeks -4.9%  
MediRox AB Key Data:
  Ticker: MROX A Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 33,858,000
(Year Ending Jan 2016).
Employees: 10
  Currency: Swedish Kronor Market Cap: N/A
  Fiscal Yr Ends: December Shares Outstanding: N/A
  Share Type: Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.